Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

Antoni Font Guiteras, Vincenza Conteduca, Daniel Wetterskog, M. T. A. Sharabiani, Enrique Grande, M. P. Fernandez Perez, Anuradha Jayaram, S. Salvi, Daniel Castellano, A. Romanel, C. Lolli, Valentina Casadio, Giorgia Gurioli, D. Amadori, S. Vazquez Estevez, Aránzazu González-del-Alba, B. Mellado, O. Fernandez Calvo, M. J. Méndez Vidal, Miguel Ángel ClimentIgnacio Durán, Ángel Rodríguez Sánchez, C. Santander, M. I. Sáez, J. Puente, D. Gasi Tandefelt, Anna Wingate, D. Dearnaley, F. Demichelis, Ugo De Giorgi, Enrique Gonzalez-Billalabeitia, Gerhardt Attard

Research output: Contribution to journalArticleResearchpeer-review

211 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Veterinary Science and Veterinary Medicine